X0306 4 2017-08-21 0 0000722830 IMMUNOMEDICS INC IMMU 0001701815 Aghazadeh Behzad C/O VENBIO SELECT ADVISOR LLC 120 W. 45TH STREET, 28TH FLOOR NEW YORK NY 10036 1 0 1 1 See Remarks 0001633313 venBio Select Advisor LLC 120 WEST 45TH STREET SUITE 2802 NEW YORK NY 10036 1 0 1 0 Call Option (right to buy) 7.00 2017-08-21 4 A 0 5000 2.8423 A 2017-08-21 2018-02-16 Common Stock, par value $0.01 per share ("Common Stock") 500000 5000 I See footnotes Put Option (obligation to buy) 7.00 2017-08-21 4 S 0 5000 0.7699 A 2017-08-21 2018-02-16 Common Stock 500000 5000 I See footnotes Call Option (right to buy) 7.00 2017-08-22 4 A 0 2500 3.2031 A 2017-08-22 2018-02-16 Common Stock 250000 7500 I See footnotes Put Option (obligation to buy) 7.00 2017-08-22 4 S 0 2500 0.7291 A 2017-08-22 2018-02-16 Common Stock 250000 7500 I See footnotes Call Option (right to buy) 7.00 2017-08-23 4 A 0 1250 3.2368 A 2017-08-23 2018-02-16 Common Stock 125000 8750 I See footnotes Put Option (obligation to buy) 7.00 2017-08-23 4 S 0 1250 0.7605 A 2017-08-23 2018-02-16 Common Stock 125000 8750 I See footnotes The securities reported herein are held on behalf of accounts managed by venBio Select Advisor LLC, a Delaware limited liability company (the "Investment Manager") and venBio Select Fund LLC, a Delaware limited liability company, a fund managed by the Investment Manager. Behzad Aghazadeh ("Dr. Aghazadeh," and together with the Investment Manager, the "Reporting Persons") serves as the portfolio manager and controlling person of the Investment Manager. The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein. The Investment Manager may be deemed a director by deputization of Immunomedics, Inc. (the "Issuer") by virtue of the fact that Dr. Agahazadeh currently serves on the board of directors of the Issuer. venBio Select Advisor LLC, by: /s/ Scott Epstein, its Chief Financial Officer & Chief Compliance Officer 2017-08-23 /s/ Behzad Aghazadeh 2017-08-23